IL155907A0 - Specific promotor of the human vascular endothelial cadherin-2-(hve-cad-2) gene and the therapeutic uses thereof - Google Patents

Specific promotor of the human vascular endothelial cadherin-2-(hve-cad-2) gene and the therapeutic uses thereof

Info

Publication number
IL155907A0
IL155907A0 IL15590701A IL15590701A IL155907A0 IL 155907 A0 IL155907 A0 IL 155907A0 IL 15590701 A IL15590701 A IL 15590701A IL 15590701 A IL15590701 A IL 15590701A IL 155907 A0 IL155907 A0 IL 155907A0
Authority
IL
Israel
Prior art keywords
hve
cad
gene
vascular endothelial
therapeutic uses
Prior art date
Application number
IL15590701A
Other languages
English (en)
Original Assignee
Cardion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardion Ag filed Critical Cardion Ag
Publication of IL155907A0 publication Critical patent/IL155907A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15590701A 2000-11-16 2001-11-16 Specific promotor of the human vascular endothelial cadherin-2-(hve-cad-2) gene and the therapeutic uses thereof IL155907A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24939000P 2000-11-16 2000-11-16
PCT/EP2001/013321 WO2002040692A2 (de) 2000-11-16 2001-11-16 Gefässendothel-spezifischer promotor des humanen vascular endothelial cadherin-2 (hve-cad-2) gens und seine therapeutischen verwendungen

Publications (1)

Publication Number Publication Date
IL155907A0 true IL155907A0 (en) 2003-12-23

Family

ID=22943270

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15590701A IL155907A0 (en) 2000-11-16 2001-11-16 Specific promotor of the human vascular endothelial cadherin-2-(hve-cad-2) gene and the therapeutic uses thereof

Country Status (5)

Country Link
EP (1) EP1392836A2 (xx)
AU (1) AU2002220711A1 (xx)
CA (1) CA2429317A1 (xx)
IL (1) IL155907A0 (xx)
WO (1) WO2002040692A2 (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756570B1 (fr) * 1996-12-03 2002-09-27 Commissariat Energie Atomique Promoteur de la ve-cadherine et ses utilisations
WO2001055214A2 (en) * 2000-01-25 2001-08-02 Novartis Ag Asthma-associated gene

Also Published As

Publication number Publication date
WO2002040692A2 (de) 2002-05-23
AU2002220711A1 (en) 2002-05-27
EP1392836A2 (de) 2004-03-03
WO2002040692A3 (de) 2002-11-14
CA2429317A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
AU1166502A (en) Human ect2 and methods of use
EP1283702A4 (en) MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
HK1068885A1 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n--
IL148657A0 (en) Stent range transducers and methods of use
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
AU6723401A (en) Antimicrobial peptides and methods of use thereof
AU2002252976A1 (en) Hydrazones and their therapeutic use
AP2002002393A0 (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
MXPA02000779A (es) Factor de activacion de la citocina altamente purificada y metodos de uso.
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
EP1161451A4 (en) HUMAN ALPHA ENDOKIN AND METHOD FOR ITS USE
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303612A3 (en) Bicyclic guanidine derivatives and their therapeutic use
IL155907A0 (en) Specific promotor of the human vascular endothelial cadherin-2-(hve-cad-2) gene and the therapeutic uses thereof
HK1045103A1 (zh) Bpi蛋白質產品於bpi蛋白質不足的人體的治療用途
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
AU2430901A (en) Human lyases and associated proteins
GB0017028D0 (en) Peptides and their therapeutic use
GB9903919D0 (en) Aminophenols and their therapeutic use
GB9920996D0 (en) Improvements in the human support of catheter leg-bags
EP1167527A4 (en) Processed human chemokines PHC-1 and PHC-2
AU2002222308A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular response
GB0006285D0 (en) Proteins and their use for diagnosis and treatment of vascular dementia